A carregar...
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity.
1. The clinical use of the antitumour agent, doxorubicin, is largely limited by the development of a cumulative dose-related cardiotoxicity. This toxicity is generally believed to be caused by the formation of oxygen free radicals. In earlier studies it was established that flavonoids, naturally occ...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1995
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1908788/ https://ncbi.nlm.nih.gov/pubmed/7582554 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|